144 results
Page 3 of 8
8-K
dkep5spxdks xl0n
8 May 20
AbbVie Completes Transformative Acquisition of Allergan
4:31pm
8-K
EX-99.1
isdyi8bte8qjg5z
7 Feb 20
AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
7:48am
8-K
EX-4.2
kgbkj
26 Nov 19
Entry into a Material Definitive Agreement
8:45am
8-K
EX-99.1
u51ebw563c0kreg
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-1.1
6pvnag9l
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-4.2
1itcaquz s0ec
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-5.1
06qgft
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.3
1gxjp9z4g 5ehkwuq8v0
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-1.1
pvz 1ypth3avoz14
23 Sep 19
Entry into a Material Definitive Agreement
4:24pm
424B5
d130iwgf1ddvde9u8dfq
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
6op2gn95y imte
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-10.1
8w5by4b
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
30zwj5pn
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
6ltx66x7ja
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
ovafqh020p1oqi3sl3r
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
fp5qp3dw
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm